Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Pfizer

New Covid boosters approved as CDC set to decide who should receive them amid rising cases

Health officials say that the Pfizer and Moderna shots likely to be available later this week

The Independent UK

US approves updated COVID vaccines to rev up protection this fall

U.S. regulators have approved updated COVID-19 vaccines from Pfizer and Moderna, shots aimed at revving up protection this fall and winter

The Independent UK

New COVID vaccines get FDA approval

Vaccines for a fall immunization drive against COVID-19 just got the green light from the Food and Drug Administration. The agency says the vaccines can protect people, as hospitalizations tick up.

WEKU

From analysis to the latest developments in health,
read the most diverse news in one place.

What you should know about new COVID shots

Updated COVID-19 shots will be part of a trio of fall vaccines that doctors hope will help avoid another “tripledemic.”

Chicago Sun-Times

FDA greenlights new COVID-19 shots for this fall - Roll Call

The FDA approved reformulated COVID-19 vaccines from Pfizer and Moderna, but deferred an expected authorization for Novavax’s vaccine.

Roll Call

Updated COVID shots are coming. They're part of a trio of vaccines to block fall viruses

Updated COVID-19 shots are coming soon, part of a trio of fall vaccines that doctors hope will help avoid another “tripledemic."

The Independent UK

3 strong and undervalued dividend stocks: Morningstar

Dividend stocks often provide steady – sometimes rising – income payments and a potential for capital gains.

The Street

Read news from The Economist, FT, and more,
with one subscription

South Africa ‘held to ransom’ by big pharma, overcharged for COVID vaccines

J&J, Pfizer charged South Africa between 15 and 33 percent more for COVID vaccine doses, contracts reveal.

Al Jazeera

The Unexpected Bad News For Novo's Ozempic In Biden's Drug Negotiations List

Drugs from AbbVie, Bristol and Merck took slots on the list of drugs subject to price cuts. But the pharmaceutical stocks were unmoved.

Investors Business Daily

Why BridgeBio's Battle With Pfizer In Heart Disease Treatment Is Just Heating Up

Shares of BBIO stock slumped Monday as analysts parsed through BridgeBio Pharma's effort to take on Pfizer in treating a heart condition.

Investors Business Daily

FDA's greenlighting of maternal RSV vaccine represents a major step forward in protecting young babies against the virus

With the Food and Drug Administration’s Aug. 21, 2023, approval of the first vaccine against respiratory syncytial virus, or RSV, for use during late pregnancy, the U.S. will soon have a major new tool at its disposal to protect infants against the highly contagious virus.

The Conversation

Who should get the new RSV vaccines? Here's everything you need to know

There are now RSV vaccines approved for older adults and for pregnant people, and antibody shots (not vaccines) available for babies. What's the difference?

LiveScience

FDA approves RSV vaccine for moms-to-be to guard their newborns

U.S. regulators have approved the first RSV vaccine for pregnant women to protect their newborns

The Independent UK

Pfizer's RSV vaccine to protect babies gets greenlight from FDA

The Food and Drug Administration has approved the first vaccine for expectant mothers to shield their babies from RSV.

WEKU

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Covid Vaccine Rally Dashed As Pfizer, Moderna Give Back Gains On Eris' Advance

Pfizer stock and Moderna stock dipped Friday — giving back some of their late Thursday gains on an upswing related to their updated Covid shots.

The Guardian - UK

Covid booster jabs could go on sale privately in UK in 2024

Health officials reiterate support for private provision as lower age limit for NHS booster vaccines raised to 65

Fortune

Management consultants can make great CEOs—but they have to get their hands dirty first

Some 47 Fortune 500 CEOs have spent time as management consultants but first took more junior roles.

The Guardian - UK

A tsunami of AI misinformation will shape next year’s knife-edge elections

If you thought social media had a hand in getting Trump elected, watch what happens when you throw AI into the mix

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

Coronavirus FAQ: Is it wiser to get a booster now or wait for the new fall booster?

Maybe it's not a full-blown summer surge but COVID numbers are ticking up. For those with concerns due to personal risk factors or the start of the school year, the booster question is top of mind.

The Street

Morningstar's 8 Favorite Healthcare Stocks

The healthcare sector has trailed far behind the overall stock market so far this year, creating 'opportunities.'

The Guardian - UK

‘Endless possibilities’: the chemists changing molecules atom by atom

A new method called ‘skeletal editing’ offers a hugely simplified way to alter matter, paving the way for world-changing innovations in personalised medicine and sustainable plastics

StockNews.com

Are Pfizer (PFE) and AbbVie (ABBV) Good Value Buys for August?

The pharma industry is poised to witness long-term growth with the introduction of generic medicines and growing demand for personalized and targeted treatments. Hence, fundamentally strong pharma stock AbbVie (ABBV) might be worth buying. However, it might not be the right time to invest in Pfizer (PFE). Keep reading.

The Independent UK

Babies should get new drug that prevents RSV, CDC panel says

A panel of U.S. health advisers is recommending that babies get a new drug to protect them against a respiratory virus

Investors Business Daily

Pfizer, Moderna Try To Squeeze Blood From A Stone. Why It Probably Won't Work.

The biggest names in Covid are updating their vaccines for a fall campaign, but that might not bolster Pfizer stock and Moderna stock.

Investors Business Daily

Pfizer Stock Wavers As Waning Demand For Covid Products Slashes Sales In Half

Pfizer stock wavered early Tuesday after the company reported massive sales and earnings declines amid lower demand for Covid products.

1 … 13 14 15 16

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Centers for Disease Control and Prevention

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.